Radiation and immunotherapy team up against hard-to-treat lymphoma
NCT ID NCT07634289
First seen Jun 08, 2026 · Last updated Jun 12, 2026 · Updated 1 time
Summary
This study tests whether giving radiation therapy before the immunotherapy drugs obinutuzumab and glofitamab can improve outcomes for people with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). About 40 adults who have already tried at least two prior treatments will receive radiation followed by 12 cycles of drug therapy. The main goal is to see how many patients achieve a complete response without severe side effects, with follow-up lasting up to 5 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Hospital
Heidelberg, Victoria, 3084, Australia
Contact Email: •••••@•••••
-
Fiona Stanley Hospital
Murdoch, Western Australia, Australia
-
Flinders Medical Centre
Bedford Park, South Australia, 5042, Australia
Contact Email: •••••@•••••
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
Contact Email: •••••@•••••
-
Townsville University Hospital
Douglas, Queensland, Australia
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.